CML lecture Flashcards
chromosome responsible for CML
philidelphia chromo
3 phases of CML progression
- chronic
- accelerated
- blast crisis
CML therapy in 70s and effect
cytoreductive agents - lower WBC counts, no effect on survival
CML therapy in 80s and effect
interferon - blast crisis deferred
- toxic
CML therapy in 90s and effect
marrow transplant
- cures some
- kills many early
important findings in 60s
philidelphia chormo - CML cells have genetic changes
important findings in 73
philadelphia gene is a translocation problem
important findings in 83
c-abl - oncogene on chromosome 9
clustered in small area (bcr)
important findings in 85
translocation results in fusion mRNA that is part BCR, part ABL
important findings in 90
BCR-ABL encodes a kinase with altered activity
other important findings in 90
BCR-ABL expression is sufficient to cause leukemia
what is BCR-ABL
kinase oncogene that transfer P to activate leukemia
what does imatinib do?
competitive inhibitor of ATP binding in BCR-ABL
how does CML become imatinib resistant?
kinase domain mutation - changes shape of receptor so imatinib can’t bind, but ATP can still bind
what has happened now
more kinase inhibitors have been produced